There is currently no clinical evidence showing that transdermal GLP-1 delivery produces meaningful weight loss results
It can vary based on things like inflation, manufacturer policies, and even the pharmacy location
Compare that to a typical diet-and-exercise weight loss program without medication, where lean mass loss is usually closer to 10-25% of total weight lost when resistance training is included and the gap becomes clear
However, compared with appetite-suppressing drugs, Vutiglabridin produces a slower onset and a smaller magnitude of weight loss [24, 25]
Commercially available under brand names such as Wegovy and Ozempic, semaglutide is celebrated for its efficacy
So when it falls, we're gonna see reduced glucose being pooled out of the bloodstream, increased liver output of glucose and adrift towards insulin resistance